On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
|
|
- Timothy Gilbert
- 8 years ago
- Views:
Transcription
1 7 Asthma
2 Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists can expect to see regularly. Pharmacists are in an ideal position to monitor treatment, counsel parents and children on the correct use of asthma inhaler devices and medication, and assist in the management of a child with asthma including in a prescribing role. Objectives On completion of this chapter you should be able to: list the common symptoms of asthma discuss the stepwise approach to the pharmacological management of asthma in children describe the different devices available to deliver asthma medication.
3 Asthma 1. The disease Asthma is a chronic inflammatory disease of the airways characterised by: reversible airflow obstruction bronchial hyper-responsiveness to a wide variety of stimulants inflammation of the airways. Histamine and other inflammatory mediators such as prostaglandins and leukotrienes are released from mast cells. Inflammatory cells, such as eosinophils, infiltrate the airways releasing inflammatory mediators that damage the bronchial epithelium. Mucosal oedema and increased mucus production also occur. The inflamed airways react to a variety of stimuli such as exercise, cold air and environmental pollutants to produce the familiar symptoms of bronchoconstriction. Most childhood asthma is atopic in nature in that it involves an allergic reaction mediated by the immunoglobulin IgE and mast cell degradation. Children can be allergic to various substances including house dust mites, pets and pollen. A family history of asthma or other atopic conditions such as hay fever is a risk factor for the development of childhood asthma. Risk factors for Asthma Genetic e.g. family history, atopy Environmental e.g. air pollution, allergens, cigarette smoke, viral infection Bronchial inflammation Bronchial hyperresponsiveness Bronchial contraction Asthmatic symptoms e.g. wheeze SOB, chest tightness, cough Risk factors for exacerbation e.g. respiratory tract infections, exercise, cold air, drugs (for example beta-blockers, NSAIDs) Symptoms The main symptoms of asthma include: wheeze shortness of breath cough chest tightness. Symptoms are often worse at night or early in the morning leading to disturbances in sleep. 81
4 Introduction to paediatric pharmaceutical care Diagnosis Diagnosis is based on symptoms, clinical and family history, response to treatment and measurement of lung function. One way to monitor lung function is by measurement of the peak expiratory flow rate (PEFR). This measures airflow in the lungs using a peak flow meter. The meter is a simple device into which the child blows as hard and as fast as they can. A reading is obtained which can be compared to a table of normal values based on height, age and sex. Reduction in peak flow reading indicates a narrowing of the airways. Asthmatic patients show variation in peak flow readings throughout the day (readings are usually lower in the morning) and improvement following bronchodilator therapy, showing reversibility. Spirometry is another test of lung function used in the diagnosis and monitoring of asthma patients. An increase in FEV1(forced expiratory volume in 1 second ) of > 12% following bronchodilator therapy supports the diagnosis of asthma. As young children are unable to use peak flow meters or perform spirometry, diagnosis in this age group can be more difficult and is usually based on clinical signs and symptoms and response to treatment. Management Most children with asthma will be managed in primary care and only those with moderate to severe exacerbations or uncontrolled asthma will require admission to hospital. Many pharmacists are involved in running asthma clinics in GP practices and hospitals offering advice on both aspects of care. The aims of treatment of asthma in children include: control of asthma symptoms prevention of exacerbations minimal use of reliever medication minimal side effects of medication achievement of best possible lung function allowing the child to lead as normal a life as possible. These can be achieved by a combination of non-pharmacological and pharmacological management. 82
5 Asthma 2. Non-pharmacological management Pharmaceutical care of children with asthma includes using non-pharmaceutical approaches. These can be summarised as prevention, monitoring and education. Control of triggers As already explained, asthma symptoms can be triggered by various factors such as reaction to dust mites, pets, exercise, cigarette smoke or infection. These triggers will vary between individuals and parents should try to identify any triggers that cause an increase in their child s asthma. These triggers should then be avoided where possible, although not all allergen avoidance strategies have shown a reduction in asthma symptoms. Preventative measures include: regular washing of bedding at high temperatures and use of mattress covers to reduce house dust mite keeping pets out of child s bedroom no smoking indoors ideally parents should not smoke at all where exercise is a trigger, the child can take a short acting beta2 agonist minutes before exercise. Use of peak flow meter Monitoring of asthma at home by use of a peak flow meter should be encouraged. This involves knowing the child s best PEFR when well and regularly recording peak flow readings on a chart. Reduction in peak flow is an indicator of worsening asthma and an increase in medication may be required to prevent a severe attack. Self management plans Self management plans have proved very helpful for adults and children alike. These detail current treatment and describe the steps to be taken in the event of worsening symptoms or reduced peak flow readings. Education Educating parents and children about the condition will often improve compliance with medication and the management of asthma. Points to cover include: what asthma is and the symptoms the difference between relievers and preventers the importance of using preventer therapy regularly when and how to use each medicine that is prescribed how each medicine works common adverse effects. Providing parents and children with other sources of information (such as organisations like Asthma UK) will prove helpful. See for more information. 83
6 Introduction to paediatric pharmaceutical care Activity 7.1 Choose one inhaler device and demonstrate its use to a colleague or member of staff. Ask for feedback on any aspect of your demonstration or explanation which was unclear. Prescription monitoring Monitoring how often prescriptions are presented can be a useful indicator of compliance with therapy and control of asthma. Excessive prescriptions for beta 2 agonists can indicate poor control of asthma, or incorrect use (take into account multidosing which can use up to 10 puffs per dose-see section 3.2). Likewise, fewer than expected prescriptions for corticosteroid inhalers or other preventer therapies can indicate poor compliance. You should take the opportunity to check how often the patient is taking the prescribed medication, check inhaler technique, counsel on correct use of medication and refer to a doctor, if appropriate. 84
7 Asthma 3. Pharmacological management Treatment of young patients with asthma will vary, depending on whether it is the chronic condition or an acute exacerbation that needs to be managed. 3.1 Chronic asthma Treatment of chronic asthma in children, as in adults, is based on a step-wise approach as recommended in the BTS/SIGN guidelines (British guideline on the management of asthma). Medicines used at each stage will depend on the age of the child. The Commission on Human Medicines (CHM) has published guidance on the use of long-acting beta 2 agonists for the management of chronic asthma. You will find details of the advice in the latest edition of BNF-C (Section ) A summary is shown below: Step Under 5 yrs 5-18 yrs 1 Mild intermittent asthma Inhaled short-acting beta 2 agonist as required. Inhaled short-acting beta 2 agonist as required. 2 Regular preventer therapy Add inhaled steroid (1st choice) microgram/day of beclometasone (or equivalent dose of other steroids).*or leukotriene receptor antagonist Add inhaled steroid (1st choice) microgram/day of beclometasone (or equivalent dose of other steroids)*.or other preventer. 3 Initial Add-on therapy Consider trial of leukotriene receptor antagonist (2-5yrs). If < 2 yrs consider going to step 4. Add inhaled long-acting beta 2 agonist and assess response. Increase steroid dose if necessary to 400microgram/day of beclometasone (or equivalent). If control still poor, try other therapies e.g. leukotriene receptor antagonist, or SR theophylline. 4 Persistent poor control Refer to paediatrician Increase dose of steroid to 800microgram/day beclometasone (or equivalent). 5 Continuous or frequent use of oral steroids N/A Maintain dose of inhaled steroids. Add daily oral steroid. Refer to paediatrician. *Doses of inhaled steroid in the BTS/SIGN guidelines are given as beclometasone. Budesonide doses are the same as beclometasone while the equivalent fluticasone dose is half that of beclometasone. Adjustments may also be needed for CFC free beclometasone inhalers depending on brand(see BNF-C) 85
8 Introduction to paediatric pharmaceutical care Key points include: start treatment at the point most appropriate to the severity of the child s asthma early use of inhaled steroids is indicated if beta2 agonist needed three times a week or more, symptomatic 3 times a week or more, child is waking one night a week or more or (in >5yrs) has experienced an exacerbation requiring oral steroids in the previous two years use lowest effective dose of steroid and try add-on therapy before increasing the steroid dose do not use long-acting beta2 agonist without inhaled corticosteroids check compliance and inhaler technique before starting new therapy review regularly step treatment up or down as necessary. Inhaled beta 2 agonists and corticosteroids are preferred to the oral route due to reduced side effects. Local side effects of inhaled steroid can include hoarseness and oral candidiasis. These can be minimised by use of a spacer device, together with advice to rinse the mouth or brush the child s teeth after the dose. If a mask is used with the spacer, the child s face should also be washed after each dose. Systemic side effects such as growth suppression and adrenal suppression can occur with inhaled steroids, particularly at high doses. It is recommended that doses of inhaled steroids in children should not exceed 800microgram/day of beclometasone and budesonide or 400microgram/day of fluticasone. The treatment should be reviewed regularly and doses reduced slowly if control of asthma allows. Activity 7.2 Mrs A presents a prescription for a salbutamol inhaler for her eight year old son. You notice from the PMR that he received one six weeks ago. On asking Mrs A how often he uses it, she tells you he uses it most mornings on waking and also during sports at school. What would you recommend? workbook page Acute asthma Depending on severity, acute exacerbations may be managed at home or may require admission to A&E or hospital. In an acute exacerbation, inhaled beta 2 agonist should be delivered via a spacer (with mask if appropriate for younger children) or nebulised in cases of severe or life threatening asthma. Multidosing, where up to 10 puffs are inhaled per dose via a spacer, is as effective as nebuliser therapy in mild to moderate attacks. This also has reduced side effects and allows the child to be managed at home. Oral steroids given early in an attack can reduce the need for hospitalisation. 86
9 Asthma Hospital treatment can involve any of the following: nebulised beta2 agonists nebulised ipratropium steroids oral or parenteral aminophylline infusion beta2 agonists by IV route oxygen magnesium sulphate. Severe asthma Severe asthma can be fatal and should be treated promptly. Signs of severe asthma in a child include: respiration tachycardia PEFR < 50% of normal too breathless to talk or feed. It is important to remember that wheeze may be absent in severe asthma. Nebulised ipratropium may be added for children with severe symptoms or who are responding poorly to beta 2 agonists. See MHRA advice on usage. Some hospitals use IV salbutamol (15microgram/kg) or terbutaline (10microgram/kg) in severe exacerbations. Short courses of steroids up to three days are recommended, although some children may require longer treatment. Aminophylline infusion may be needed for severe asthma. A loading dose should be given unless the child is on regular oral theophylline. Nebulised beta 2 agonists can be given until the child has improved enough to change to multidosing with a metered dose inhaler and spacer. Discharge can take place when the child is stable on 3-4 hourly inhaled bronchodilators, with PEFR > 75% of best. Regular therapy should then be reviewed and inhaler technique checked. A written self management plan should be provided to assist parents caring for their asthmatic child. 3.3 Devices There are various devices available to deliver inhaled asthma medication. These include: metered dose inhaler (MDI) dry powder inhaler breath activated inhaler. In children, use of a spacer device with a metered dose inhaler is recommended. This allows more medication to reach the lungs, eliminates the need for co-ordination of inhalation and actuation, and reduces local side effects. Spacer devices with an integral face mask are available for young children and babies which reduces the need to use nebulisers in this age group. 87
10 Introduction to paediatric pharmaceutical care Choice of device will depend on the drug, the age of the child, ability of child to use the device effectively and patient preference. Most children below school age are unlikely to be able to use dry powder inhalers. under 5yrs 5yrs and over beta 2 agonists MDI + spacer MDI + spacer or dry powder inhaler steroids MDI + spacer MDI + spacer Unlike steroid inhalers, beta 2 agonists must be taken to school. However, children may be reluctant to use a spacer at school and a dry powder inhaler may be preferred. Parents and children should be taught how to use the chosen device and should then demonstrate the technique to ensure they have understood and are using it effectively. Pharmacists must be competent in the use of the different devices before demonstrating to patients. Activity 7.3 A four year-old girl was admitted to hospital with a severe asthma attack, her second in eight weeks. She needed nebulised salbutamol, oral prednisolone and intravenous aminophylline. a: What side effect is common to all three drugs and should be monitored for? The child is to be discharged on salbutamol and beclometasone inhalers via a spacer. The beclometasone is an addition to therapy. b: What step of the BTS/SIGN guidelines is she now on? c: List three reasons why a spacer is recommended for use with a steroid MDI. d: What counselling points would you cover prior to discharge? workbook page 15 British Guideline on the Management of Asthma May 2008 BTS/Sign ( BNF for Children July
Medicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
More informationGuidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
More informationASTHMA IN INFANTS AND YOUNG CHILDREN
ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to
More informationInformation for Behavioral Health Providers in Primary Care. Asthma
What is Asthma? Information for Behavioral Health Providers in Primary Care Asthma Asthma (AZ-ma) is a chronic (long-term) lung disease that inflames and narrows the airways. Asthma causes recurring periods
More informationBackground information
Background information Asthma Asthma is a complex disease affecting the lungs that can be managed but cannot be cured. 1 Asthma can be controlled well in most people most of the time, although some people
More informationunderstanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
More informationTreatment of Asthma. Talk to your doctor about the various medications available to treat asthma.
Please call 911 if you think you have a medical emergency. Treatment of Asthma The goals of asthma therapy are to prevent your child from having chronic and troublesome symptoms, to maintain your child's
More informationChronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
More informationGCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A09-1661-01A)
GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1 Pre-release Article for Examination in January 2010 JD*(A09-1661-01A) 2 BLANK PAGE 3 Information for Teachers The attached article on asthma is based on some
More informationmedicineupdate to find out more about this medicine
medicineupdate Asking the right questions about new medicines Seretide for chronic obstructive pulmonary disease What this medicine is 1 What this medicine treats 2 Other medicines available for this condition
More informationChildhood Asthma / Wheeze
Childhood Asthma / Wheeze Symptoms Asthma causes a range of breathing problems. These include wheezing, feeling of tightness in the lungs/chest and a cough (often in the night or early morning). The most
More informationThe Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
More informationMedication and Devices for Chronic Obstructive Pulmonary Disease (COPD)
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD) Patients with COPD take a wide variety of medicines to manage their symptoms these include: Inhaled Short Acting Bronchodilators
More informationYOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST...
YOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST... ...HERE S WHAT TO EXPECT You have been referred to an allergist because you have or may have asthma. The health professional who referred you wants you to
More informationAsthma Care. Of course, your coach is there to answer any questions you have about your asthma, such as:
Asthma Care All Health Coaches in the Asthma Care Management program are registered or certified respiratory therapists. Your coach will listen to your story of living with asthma. This will help your
More informationAdult asthma Hope and support
Adult asthma Hope and support at every step Contents What is asthma? 4 What are the symptoms of asthma? 4 Who gets asthma? 4 What causes asthma? 5 What can treatment offer? 7 Diagnosing asthma 7 What your
More informationVirginia Tech Departmental Policy 27 Sports Medicine Key Function:
Virginia Tech Departmental Policy 27 Sports Medicine Key Function: Review: Yearly Director of Athletic Training Title: Management of Asthma in Athletes Section: Treatment S-A Safety POLICY STATEMENT: This
More informationThe Right Medicines Can Help You Get Control of Asthma. BlueCare SM TennCareSelect
The Right Medicines Can Help You Get Control of Asthma BlueCare SM TennCareSelect WHEEZING. COUGHING. SHORTNESS OF BREATH. CHEST TIGHTNESS. If you or a family member has asthma, you know these symptoms
More informationII. ASTHMA BASICS. Overview of Asthma. Why do I need to know about asthma?
II. ASTHMA BASICS Overview of Asthma Why do I need to know about asthma? In the United States, asthma is the most common chronic childhood illness. Asthma affects an estimated 4.8 million children nationally,
More informationCOPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
More informationUnderstanding and Controlling Asthma Attacks. Information for parents
Understanding and Controlling Asthma Attacks Information for parents Your child was recently seen by a doctor for asthma. This guide will help you gain a better understanding about your child's recent
More informationPATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE
PATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE The content of this booklet was developed by Allergy UK. MSD reviewed this booklet to comment
More informationSTAYING ASTHMA FREE. All you need to know about preventers. www.spacetobreathe.co.nz
STAYING ASTHMA FREE All you need to know about preventers www.spacetobreathe.co.nz HELPING YOUR CHILD BREATHE MORE EASILY GETTING TO KNOW THE PREVENTER What is a preventer? When do you use it? How do they
More informationDoncaster & Bassetlaw Medicines Formulary
Doncaster & Bassetlaw Medicines Formulary Section 3.2: Corticosteroids Beclometasone 50, 100 and 250micrograms/dose Clickhaler Clenil Modulite (Beclometasone CFC free) 50, 100, and 250micrograms/dose MDI
More informationAn Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
More informationPre-Operative Services Teaching Rounds 2 Jan 2011
Pre-Operative Services Teaching Rounds 2 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
More informationIn case of an urgent concern or emergency, call 911 or go to the nearest emergency department right away.
Asthma Basics Patient and Family Education This teaching sheet contains general information only. Talk with your child s doctor or a member of your child s healthcare team about specific care of your child.
More informationWhat You And Your Family Can Do About Asthma
GLOBAL INITIATIVE FOR ASTHMA What You And Your Family Can Do About Asthma BASED ON THE GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION NHLBI/WHO WORKSHOP REPORT NATIONAL INSTITUTES OF HEALTH NATIONAL
More informationDRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL
International Journal of Pharmaceutical Applications ISSN 0976-2639, Online ISSN 2278 6023 Vol 3, Issue 2, 2012, pp 297-305 http://www.bipublication.com DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A
More informationTAKING CARE OF YOUR ASTHMA
TAKING CARE OF YOUR ASTHMA WHAT IS ASTHMA? Asthma is a disease that affects the lungs. If you have asthma, you have it all the time, but will have an asthma attack only when something, known as a trigger,
More informationEar Infections Asthma in childhood asthma in childhood
Asthma Ear Infections in childhood asthma in childhood Asthma in childhood is common and it can be serious. About one in six children (aged less than 15 years) in Western Australia are affected by asthma.
More informationSevere asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
More informationWhat You Should Know About ASTHMA
What You Should Know About ASTHMA 200 Hospital Drive Galax, VA 24333 (276) 236-8181 www.tcrh.org WHAT IS ASTHMA? It s a lung condition that makes breathing difficult. The cause of asthma is not known.
More information5. Treatment of Asthma in Children
Treatment of sthma in hildren 5. Treatment of sthma in hildren 5.1 Maintenance Treatment 5.1.1 rugs Inhaled Glucocorticoids. Persistent wheezing in children under the age of three can be controlled with
More informationASTHMA FACTS. Prevalence is increasing in many countries, especially in children.
ASTHMA FACTS Asthma is one of the most common chronic diseases worldwide. It is the most common chronic illness in childhood. Unlike most other chronic diseases, asthma often appears early in life and
More informationBreathe Easy: Asthma and FMLA
This article was published in the FMLA Policy, Practice, and Legal Update newsletter, by Business & Legal Reports, Inc. (BLR). BLR is a nationally recognized publisher of regulatory and legal compliance
More informationTreatments for allergy are usually straightforward, safe and effective. Common treatments include:
Allergy Medications The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient
More informationCOPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
More informationAsthma Management Policy
Asthma Management Policy Policy Number 003 Version Number 1.01 Drafted by Executive Officer Approved Date: Review Date: Responsibility Relevant Policies Relevant Standards and Regulations Bubup Womindjeka
More informationDrug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS
Drug therapy 6 6.1 What is the role of bronchodilators in COPD? 52 SHORT-ACTING BETA AGONISTS 6.2 How do short-acting beta agonists work? 52 6.3 What are the indications for their use? 52 6.4 What is the
More informationAsthma Triggers. What are they and what can be done about them?
Asthma Triggers What are they and what can be done about them? This brochure has been developed for the community by Asthma Australia It provides information about: Asthma triggers What you can do about
More informationPharmacology of the Respiratory Tract: COPD and Steroids
Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationSeasonal Allergies. 1995-2012 The Patient Education Institute, Inc. www.x-plain.com im010101 Last reviewed: 05/30/2012 1
Seasonal Allergies Introduction Seasonal allergies are allergies that develop during certain times of the year. Seasonal allergies are usually a response to pollen from trees, grasses, and weeds. Constant
More informationSo You Have Asthma NIH Publication No. 07-5248 March 2007
So You HaveAsthma So You HaveAsthma NIH Publication No. 07-5248 March 2007 Contents Introduction.......................................................1 Asthma Some Basics..............................................3
More informationBetter Breathing with COPD
Better Breathing with COPD People with Chronic Obstructive Pulmonary Disease (COPD) often benefit from learning different breathing techniques. Pursed Lip Breathing Pursed Lip Breathing (PLB) can be very
More informationAsthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California
Asthma in Infancy, Childhood and Adolescence Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California Major Health Problem in Childhood Afflicts 2.7 million children in the USA
More informationCough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP.
COUGH Cough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP. A cough in a child seems to cause more concern, even when it has not been present very long, whereas in adults
More informationRoyal Manchester Children s Hospital. Asthma. Information For Parents and Carers. Ward: Ward Telephone Number: Consultant:
Royal Manchester Children s Hospital Asthma Information For Parents and Carers Ward: Ward Telephone Number: Consultant: Understanding asthma Asthma is a common condition that affects approximately 1 in
More informationSIGN 141 British guideline on the management of asthma. A national clinical guideline. Evidence
SIGN 141 British guideline on the management of asthma A national clinical guideline October 2014 Evidence KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High quality
More informationASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica
ASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica Rachel Borovina, MSIV Lisa Troeger, MSIV University of California San Francisco IHCAI FOUNDATION 2001
More informationAsthma. Micah Long, MD
Asthma Micah Long, MD Goals Define the two components of asthma. Describe the method of action and uses for: Steroids (inhaled and IV) Quick Beta Agonists (Nebs and MDIs) The "Others" Magnesium, Epi IM,
More informationComplete these questions before reading the tutorial. Discuss the answers with your colleagues.
Asthma and Anaesthesia 16/05/05 Dr Iain Wilson Consultant Anaesthetist Royal Devon and Exeter Hospital UK email: iain.wilson5@virgin.net Self assessment Complete these questions before reading the tutorial.
More informationAsthma Best Practice Guidelines
Royal Children s Hospital Asthma Best Practice Guidelines October 1999 Asthma Strategy Group www.rch.unimelb.edu.au/intranet/genmed/asthmabestpractice.htm These guidelines have been produced specifically
More informationInetCE 146-000-01-001-H01
The National Asthma Education Prevention Program (NAEPP II) Guidelines for the Treatment of Asthma: Implications for the Pharmacist (Manuscript Updated December 2000) InetCE 146-000-01-001-H01 Theresa
More informationThings you might want to ask about asthma
Things you might want to ask about asthma This information is from Asthma UK. We are a charity that helps people with asthma. EasyRead version What is asthma? If you have asthma your airways do not work
More informationStrategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology
Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences
More informationLogistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.
. DSHS Grand Rounds Logistics Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.org Streamlined registration for individuals not requesting
More informationCompare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
More informationHow to use FENO-guided asthma control in routine clinical practice
How to use FENO-guided asthma control in routine clinical practice Asthma is a chronic inflammatory disease of the airways. This has implications for the diagnosis, management and potential prevention
More informationClassifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age
Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age Components of Severity Symptoms Intermittent 2 days/week Classification of Asthma Severity (0 4 years of age) Persistent
More informationBritish Guideline on the Management of Asthma
101 British Guideline on the Management of Asthma A national clinical guideline May 2008 revised May 2011 KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High quality meta-analyses,
More informationT HE ROLE OF THE PHARMACIST IN IMPROVING ASTHMA CARE NIH PUBLICATION NO. 95-3280 JULY 1995 NATIONAL INSTITUTES. National Heart, Lung,
T HE ROLE OF THE PHARMACIST IN IMPROVING ASTHMA CARE NIH PUBLICATION NO. 95-3280 JULY 1995 NATIONAL INSTITUTES OF HEALTH National Heart, Lung, and Blood Institute TABLE OF CONTENTS Preface.................................i
More information"Respiratory Problems in Swimmers: How to keep Swimmers Afloat" and in the Pool!
"Respiratory Problems in Swimmers: How to keep Swimmers Afloat" and in the Pool! Charles Siegel, MD Associate Clinical Professor University of Missouri @ Kansas City School of Medicine USA Swimming does
More informationControlling Your Asthma Patient Education Guide
Controlling Your Asthma Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T PHYSICIANS AND THE CHEST FOUNDATION Controlling Your Asthma Patient Education Guide Single copies are free. Additional
More informationAsthma and COPD Awareness
Asthma and COPD Awareness Molina Breathe with Ease sm and Chronic Obstructive Pulmonary Disease Molina Healthcare of Michigan Fall 2012 Importance of Controller Medicines Asthma is a disease that causes
More informationF r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease
Lung Disease page 1 Q: What is lung disease? A: Lung disease refers to disorders that affect the lungs, the organs that allow us to breathe. Breathing problems caused by lung disease may prevent the body
More information4 Pharmacological management
4 Pharmacological management The aim of asthma management is control of the disease. Control of asthma is defined as: no daytime symptoms no night time awakening due to asthma no need for rescue medication
More informationCOPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
More informationThe asthmatic patient and sedation
The asthmatic patient and sedation Introduction The sedation practitioner is often faced with difficult questions to answer before the administration of sedation. Our guidelines say clearly that we are
More informationAsthma. A Guide for Patients and Families. The Diana L. and Stephen A. Goldberg Center for Community Pediatric Health
CHILDREN S NATIONAL MEDICAL CENTER The Diana L. and Stephen A. Goldberg Center for Community Pediatric Health Asthma A Guide for Patients and Families Kohl s is proud to partner with Children s National
More informationSERETIDE Fluticasone propionate/salmeterol xinafoate Consumer Medicine Information
SERETIDE Fluticasone propionate/salmeterol xinafoate Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start using Seretide. This leaflet answers some
More informationUnderstanding COPD. Carolinas Healthcare System
Understanding COPD Carolinas Healthcare System 2013 This self-directed learning module contains information about the pathophysiology, diagnosis, and treatment of COPD. Target Audience: All RNs and LPNs
More informationObjectives. Asthma Management
Objectives Asthma Management BREATHE Conference Allergy and Asthma Specialists PC Christine Malloy MD March 22, 2013 Review the role of inflammation in asthma Discuss the components of the EPR-3 management
More informationUnderstanding Cough, Wheezing and Noisy Breathing in Children. Introduction
Understanding Cough, Wheezing and Noisy Breathing in Children Introduction Symptoms such as cough, wheezing or noisy breathing can be caused by a number of conditions. When these occur, it is natural for
More informationThere is no cure for COPD Chronic Bronchitis Emphysema
Live Well With COPD Chronic Obstructive Pulmonary Disease, or COPD is a lung disease. People with COPD have a hard time getting air in and out of their lungs. There is no cure for COPD. COPD is also commonly
More informationMaking a Difference in the Management of Asthma: A Guide for Respiratory Therapists
Making a Difference in the Management of Asthma: A Guide for Respiratory Therapists U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute
More informationPackage leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate
Package leaflet: Information for the patient Bricanyl Tablets 5 mg terbutaline sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationManagement of Asthma
Federal Bureau of Prisons Clinical Practice Guidelines May 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant
More informationThe Problem with Asthma. Ruth McArthur, Practice Nurse/Trainer
The Problem with Asthma Ruth McArthur, Practice Nurse/Trainer Getting the diagnosis right! Asthma or COPD? History taking is key Both are inflammatory conditions with different mechanisms & mediators Diagnostic
More informationA ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy.
A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy. RAGWITEK is a prescription medicine used for sublingual (under the tongue) immunotherapy to treat ragweed pollen allergies
More informationBEST PRACTICE EVIDENCE BASED GUIDELINE
BEST PRACTICE EVIDENCE BASED GUIDELINE MANAGEMENT OF ASTHMA IN CHILDREN AGED 1-15 YEARS. 2005 PAEDIATRIC SOCIETY OF NEW ZEALAND HEALTH OF OUR CHILDREN: WEALTH OF OUR NATION WWW.PAEDIATRICS.ORG.NZ Page
More informationUNDERSTANDING AND LEARNING ABOUT STUDENT HEALTH
Teacher Workshop Curriculum UNDERSTANDING AND LEARNING ABOUT STUDENT HEALTH Written by Meg Sullivan, MD with help from Marina Catallozzi, MD, Pam Haller MDiv, MPH, and Erica Gibson, MD UNDERSTANDING AND
More informationMEDICATION GUIDE. SYMBICORT 80/4.5 (budesonide 80 mcg and formoterol fumarate dihydrate 4.5 mcg) Inhalation Aerosol
MEDICATION GUIDE SYMBICORT 80/4.5 (budesonide 80 mcg and formoterol fumarate dihydrate 4.5 mcg) Inhalation Aerosol SYMBICORT 160/4.5 (budesonide 160 mcg and formoterol fumarate dihydrate 4.5 mcg) Inhalation
More informationSteroid treatment in cystic fibrosis
Steroid treatment in cystic fibrosis Factsheet March 2013 Steroid treatment in cystic fibrosis Introduction This factsheet contains information on steroid treatment in cystic fibrosis, including the different
More informationEmphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide.
Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema involves damage to the air sacs in the lungs. This
More informationCOPD What Is It? Why is it so hard to catch my breath? What does COPD feel like? What causes COPD? What is an exacerbation (ig-zas-er-bay-shun)?
Attitudes and Beliefs 4 COPD What Is It? Why is it so hard to catch my breath? COPD is a disease that damages the lungs. In a healthy lung, the airways are open and the air sacs fill up with air. Then
More informationwritten by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in
More informationAsthma Care Audit Instructional Guide
Asthm ma Care Audit Instructional Guide PRIMIS development of the Asthma Care audit tool has been funded by Boehringer Ingelheim. Boehringer Ingelheim has undertakenn a medico legal revieww but PRIMIS
More informationAsthma Guidance for Birmingham Schools.
Asthma Guidance for Birmingham Schools. May 2004 RECOMMENDED ASTHMA GUIDANCE FOR SCHOOL STAFF* This guidance is intended to complement the local Birmingham Administration and Management of Prescribed Medicines
More information- Woody Kageler, M.D.
Dear Parent/Guardian, We all want our children with asthma to be healthy! Asthma can be a frightening experience for kids, as well as their parents. Let Darby BoIngg be your partner, along with your physician,
More informationGuideline on the clinical investigation of medicinal products for the treatment of asthma
22 October 2015 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the clinical investigation of medicinal products for the treatment of Draft Agreed by Respiratory
More informationBefore prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines.
Formulary Guidance for Management of COPD patients Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines. For inhaler
More informationAsthma POEMs. Patient Orientated Evidence that Matters
ASTHMA POEMs Asthma POEMs Patient Orientated Evidence that Matters Developed by the Best Practice Advocacy Centre Level 8, 10 George Street PO Box 6032 Dunedin Phone 03 4775418 Fax 03 4772622 Acknowledgement
More informationTests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
More informationTHE EUROPEAN COMMUNITY RESPIRATORY HEALTH SURVEY II ECRHS II LUNG FUNCTION PROTOCOL, DATA SHEETS AND LUNG FUNCTION QUESTIONNAIRE
THE EUROPEAN COMMUNITY RESPIRATORY HEALTH SURVEY II ECRHS II LUNG FUNCTION PROTOCOL, DATA SHEETS AND LUNG FUNCTION QUESTIONNAIRE Project Leaders: Prof Peter Burney Dr Deborah Jarvis For further information:
More informationAsthma. Parent and Carer Information
Asthma Parent and Carer Information Contents 4 What is Asthma? 4 The Causes of Asthma 4 What Happens During an Asthma Attack? 6 Common Symptoms of Asthma 7 Different Types of Asthma 9 How to Assess Your
More informationThe patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
More informationNote for guidance on clinical investigation of medicinal products for treatment of asthma
1 2 3 27 June 2013 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Note for guidance on clinical investigation of medicinal products for treatment of asthma Draft Draft
More informationAllergies and Autoimmune Inner Ear Disease
Allergies and Autoimmune Inner Ear Disease Allergy is the term used to describe an over-reaction of the body to a substance that is normally harmless to most people. This substance is called an allergen,
More informationChronic obstructive pulmonary disease
12 Chronic obstructive pulmonary disease Anna Murphy Case study and questions Day 1 Mr LT, a 68-year-old man, attended his general practitioner s (GP s) surgery for a routine check-up. He had been diagnosed
More information